Skip to main content

A Randomized, Controlled, Phase 3 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment in Patients with Hepatic-Dominant Ocular Melanoma

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Delcath Systems, Inc.

Start Date

March 1, 2016

End Date

February 28, 2022
 

Administered By

Duke Cancer Institute

Awarded By

Delcath Systems, Inc.

Start Date

March 1, 2016

End Date

February 28, 2022